Subjects | n=198 | n=198 | |
Week 12 (primary end-point) | n=157 | n=172 | |
Least squares change from baseline | −5.4±9.68 | −2.1±9.29 | |
Difference from placebo (95% CI) | | 3.3 (−21.1–27.7) | 0.790 |
Day 2 | n=178 | n=185 | |
Least squares change from baseline | 5.1±7.79 | 32.3±7.62 | |
Difference from placebo (95% CI) | | 27.2 (8.2–46.2) | 0.005 |
Week 6 | n=167 | n=179 | |
Least squares change from baseline | −5.6±9.63 | 22.0±9.29 | |
Difference from placebo (95% CI) | | 27.6 (3.3–52.0) | 0.026 |